Medicure Inc. (CVE:MPH – Get Free Report)’s share price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$1.16 and traded as high as C$1.34. Medicure shares last traded at C$1.34, with a volume of 100 shares changing hands.
Medicure Stock Performance
The firm has a market cap of C$13.98 million, a price-to-earnings ratio of -4.06 and a beta of 1.09. The firm’s 50 day moving average is C$1.16 and its 200-day moving average is C$1.14. The company has a debt-to-equity ratio of 4.65, a quick ratio of 1.29 and a current ratio of 2.03.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Recommended Stories
- Five stocks we like better than Medicure
- What is a Microcap Stock? Everything You Need to Know
- 3 Stocks Poised to Benefit From Google’s AI Breakthough
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3 Stocks You’ll Wish You Bought Before 2026
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
